Amantadine Therapy for Cognitive Impairment in Long COVID

NCT06055244 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Long COVID
Post-COVID19 Condition
Post-Acute COVID19 Syndrome

Interventions

DRUG: Amantadine

Sponsor

Ohio State University